Psychedelics Today

Shannon Clare Petitt - MAPS, Zendo and an update on MDMA's status

Informações:

Sinopsis

  Download Joe and Kyle talk to Shannon Clare Petitt about the current state of MDMA research and what MAPS needs to do in the next number of months with the FDA as the phase three trials become approved. A few days after the interview the New York Times reported that the phase three research was approved. Shannon's story is great and optimistic. If you are interested in how to get a job in the psychedelic field, this is certainly an episode you'll want to listen to. We also discuss some possible tweaks to the studies that could be done that may yield interesting results, and also why MAPS is taking the approach that they are (its the most straightforward way to push the research through the FDA).   Here is Shannon's bio from the MAPS staff page. Shannon Clare Petitt, M.A., MFTI, Therapist Training Program Coordinator and Zendo Project Community Engagement Coordinator Shannon received her Master’s in Integral Counseling Psychology from the California Institute of Integral Studies in 2014, with a practic